4Filing Date: Oct 15, 2026
Hims & Hers Health 4: CLO sold 3,461 shares (Oct 15, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001773751-26-000227
Total Value$100.6K
Trades1
Insiders1
Transaction Details
Boughton Soleil
Chief Legal Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-3.46K
Price$29.06
Total Value$100.6K
Shares Owned After297.35K
Transaction DateOct 14, 2026
10b5-1
Footnotes ▸
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
Post-Transaction Holdings
Boughton Soleil · Chief Legal Officer
| Security | Shares | Change |
|---|---|---|
| Class A Common Stock | 297.35K | -3.46K (-1.15%) |
auto_awesomeDeep Analysis
Deep Analysis
Hims & Hers Chief Legal Officer Soleil Boughton sold 3,461 shares for $100,577 under a Rule 10b5-1 plan, trimming her stake by about 1.2% and leaving her 297,348 shares.
lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-10-14
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Hims & Hers Health, Inc. (HIMS)
CIK: 0001773751
--- Reporting Owner ---
Name: Boughton Soleil
CIK: 0001837817
Role: Officer (Chief Legal Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Class A Common Stock
Date: 2026-10-14 | Code: S (Open market sale)
Shares: -3,461 | Price: $29.06
Total Value: $100,576.66
Shares Owned After: 297,348 | Ownership: D (Direct)
Footnotes:
[F1] The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
--- Footnotes (Complete Index) ---
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
--- Signature ---
/s/ /s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton (2026-10-15)